Provided by Tiger Fintech (Singapore) Pte. Ltd.

ImmuCell

6.09
+0.06001.00%
Post-market: 6.090.00000.00%16:04 EDT
Volume:4.75K
Turnover:28.86K
Market Cap:55.09M
PE:30.35
High:6.14
Open:6.14
Low:6.04
Close:6.03
52wk High:7.60
52wk Low:3.38
Shares:9.05M
Float Shares:6.02M
Volume Ratio:0.15
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2007
EPS(LYR):-0.2641
ROE:6.61%
ROA:3.02%
PB:1.84
PE(LYR):-23.06

Loading ...

Immucell reports preliminary Q3 revenue $5.5M vs. $6M last year

TIPRANKS
·
Oct 08

ImmuCell Corp - Q3 2025 Prelim Sales $5.5 Mln, Down 8% From Q3 2024

THOMSON REUTERS
·
Oct 08

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

GlobeNewswire
·
Oct 08

Immucell Appoints New CEO Olivier te Boekhorst

TIPRANKS
·
Oct 01

BRIEF-Immucell Announces Selection Of Its Next President And CEO

Reuters
·
Sep 30

ImmuCell Names Former Idexx Laboratories Exec As Its Next CEO

Dow Jones
·
Sep 30

Immucell appoints Olivier te Boekhorst CEO

TIPRANKS
·
Sep 30

ImmuCell Announces Selection of Its Next President and CEO

THOMSON REUTERS
·
Sep 30

ImmuCell Corp - Selects Olivier TE Boekhorst as President and CEO

THOMSON REUTERS
·
Sep 30

Press Release: ImmuCell Announces Selection of its Next President and CEO

Dow Jones
·
Sep 30

ImmuCell Corp - on August 20, Extended $1 Mln Line of Credit With Mcb Through September 11, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 25

ImmuCell Corporation Extends $1 Million Line of Credit with Maine Community Bank Through 2026

Reuters
·
Aug 25

ImmuCell Q2 2025 Earnings Call Summary and Q&A Highlights: Strategic Expansion and FDA Approval Challenges

Earnings Call
·
Aug 15

ImmuCell Corporation Unveils Presentation Highlighting Strategic Growth Opportunities and Innovations in Animal Health Solutions

Reuters
·
Aug 15

ImmuCell Q2 EPS $0.06 Up From $(0.20) YoY, Sales $6.445M Up From $5.473M YoY

Benzinga
·
Aug 15

BRIEF-ImmuCell Corporation Q2 EPS USD 0.06

Reuters
·
Aug 15

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

THOMSON REUTERS
·
Aug 15

ImmuCell Corporation Q2 Pretax Profit USD 504 Thousand

THOMSON REUTERS
·
Aug 15

ImmuCell Corporation Q2 Net Income USD 502 Thousand

THOMSON REUTERS
·
Aug 15

ImmuCell Corp - Reducing Product Development Expenses and Exploring Potential Strategic Options for Product Opportunity

THOMSON REUTERS
·
Aug 15